文献速递腹部介入CTMR

LI-RADS分类与小单发肝细胞癌治疗结局相关:手术切除与射频消融的比较

LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
PubMed 文献 · Eur Radiol · 2023-08-01

这项回顾性研究纳入2014至2016年间357例接受手术切除(n=209)或射频消融(n=148)的单发≤3 cm肝细胞癌患者,评估LI-RADS分类与治疗结局的关系。倾向性评分匹配后,手术切除的5年局部肿瘤进展率低于射频消融(1.4% vs. 14.9%,p=0.001),在LR-M亚组中差异未达统计学显著(0% vs. 34.4%,p=0.062)。LI-RADS分类是与总生存、无复发生存和局部肿瘤进展相关的唯一危险因素。

要点

  • 手术切除的5年局部肿瘤进展率低于射频消融(1.4% vs. 14.9%,p=0.001)。
  • LR-M肝细胞癌射频消融后1年内局部肿瘤进展风险较手术切除陡增。
  • LI-RADS分类是与总生存(HR 3.79)、无复发生存(HR 2.12)和局部肿瘤进展(HR 2.89)相关的唯一危险因素。

核心结论

  • LI-RADS分类与肝细胞癌治疗结局相关,支持手术切除在局部肿瘤进展方面优于射频消融,尤其对LR-M类肝细胞癌。

研究设计与样本

  • 回顾性研究纳入2014至2016年间357例接受手术切除(n=209)或射频消融(n=148)的单发≤3 cm肝细胞癌患者,分配LI-RADS分类,并在倾向性评分匹配前后比较结局。

诊断标准与关键数值

  • 共357个肝细胞癌病灶,其中294个为LR-4/5、63个为LR-M;倾向性评分匹配后每组78例,手术切除组和射频消融组分别有10个和11个LR-M病灶。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • LR-M肝细胞癌手术切除与射频消融的5年局部肿瘤进展率比较(0% vs. 34.4%)p=0.062,未达统计学显著。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess whether the Liver Imaging Reporting and Data System (LI-RADS) category is associated with the treatment outcomes of small single hepatocellular carcinoma (HCC) after surgical resection (SR) and radiofrequency ablation (RFA).

METHODS: This retrospective study included 357 patients who underwent SR (n = 209) or RFA (n = 148) for a single HCC of ≤ 3 cm between 2014 and 2016. LI-RADS categories were assigned. Overall survival (OS), recurrence-free survival (RFS), and local tumor progression (LTP) rates after treatment were compared according to the LI-RADS category (LR-4/5 vs. LR-M) before and after propensity score matching (PSM). Prognostic factors for treatment outcomes were assessed.

RESULTS: In total, 357 patients (mean age, 59 years; men, 272) with 357 HCCs (294 LR-4/5 and 63 LR-M) were included. After PSM (n = 78 in each treatment group), there were 10 and 11 LR-M HCCs in the SR and RFA group, respectively. There were no significant differences in OS or RFS. However, SR provided a lower 5-year LTP rate than RFA (1.4% vs. 14.9%, p = 0.001). SR provided a lower 5-year LTP rate than RFA for LR-M HCCs (0% vs. 34.4%, p = 0.062) and LR-4/5 HCCs (1.5% vs. 12.0%, p = 0.008). The LI-RADS category was the sole risk factor associated with poor OS (hazard ratio [HR] 3.79, p = 0.004), RFS (HR 2.12; p = 0.001), and LTP (HR 2.89; p = 0.032).

CONCLUSION: LI-RADS classification is associated with the treatment outcome of HCC, supporting favorable outcomes of SR over RFA for LTP, especially for HCCs categorized as LR-M.

CLINICAL RELEVANCE STATEMENT: Liver Imaging Reporting and Data System category has a potential prognostic role, supporting favorable outcomes of surgical resection over radiofrequency ablation for local tumor progression, especially for hepatocellular carcinoma categorized as LR-M.

KEY POINTS: • SR provided a lower 5-year LTP rate than RFA for HCCs categorized as LR-M (0% vs. 34.4%, p = 0.062) and HCCs categorized as LR-4/5 (1.5% vs. 12.0%, p = 0.008). • There is a steeply increased risk of LTP within 1 year after RFA for LR-M HCCs, compared to SR. • The LI-RADS category was the sole risk factor associated with poor OS (HR 3.79, p = 0.004), RFS (HR 2.12; p = 0.001), and LTP (HR 2.89; p = 0.032) in patients with HCC of ≤ 3 cm treated with SR or RFA.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Min JH, Lee MW, Rhim H, et al. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation. Eur Radiol. 2023. PMID: 37526668. doi:10.1007/s00330-023-09998-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。